Kamada (KMDA) Change in Working Capital (2020 - 2026)
Kamada's (KMDA) quarterly Change in Working Capital came in at -$12.1 million in Q1 2026, up 2.5% YoY from -$11.8 million in Q1 2025, and down 2414.52% on a QoQ basis from -$482000.0 in Q4 2025.
Kamada (KMDA) Change in Working Capital (2020 - 2026) Analysis & Trends
Kamada (KMDA) has 7 years of Change in Working Capital data on file, last reported at -$12.1 million in Q1 2026.
- Quarterly Change in Working Capital rose 2.5% year-over-year to -$12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.4 million (down 410.03% YoY) and the FY2025 annual result came in at -$17.7 million, down 254.93% from the prior year.
- Change in Working Capital slipped to -$12.1 million in Q1 2026, from -$482000.0 in the prior quarter.
- In the past five years, Change in Working Capital ranged from a high of $13.0 million in Q3 2024 to a low of -$12.4 million in Q1 2025.
- A 5-year average of -$377208.7 and a median of -$482000.0 in 2025 frame the typical range for Change in Working Capital.
- Annual changes were most pronounced in 2022 — Change in Working Capital jumped 423.97% — and 2023, when it sank 2048944.59%.
- Tracing KMDA's Change in Working Capital over 5 years: stood at $11.6 million in 2022, then plunged by 115.06% to -$1.8 million in 2023, then soared by 126.66% to $467000.0 in 2024, then slumped by 203.21% to -$482000.0 in 2025, then slumped by 2414.52% to -$12.1 million in 2026.
- The last three Change in Working Capital figures came in at -$12.1 million (Q1 2026), -$482000.0 (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -164.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kamada | 457.71 Mn | 428.24 Mn | 22.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.12 Mn |
| Mar 31, 2026 | -12.12 Mn |
| Dec 31, 2025 | -482,000.00 |
| Dec 31, 2025 | -482,000.00 |
| Sep 30, 2025 | -1.55 Mn |
| Sep 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Mar 31, 2025 | -12.43 Mn |
| Mar 31, 2025 | -12.43 Mn |
| Dec 31, 2024 | 467,000.00 |
| Dec 31, 2024 | 467,000.00 |
| Sep 30, 2024 | 13.01 Mn |
| Sep 30, 2024 | 13.01 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | -6.62 Mn |
| Mar 31, 2024 | -6.62 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Dec 31, 2023 | -1.75 Mn |